Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications effect pharmacotherapy attention deficit hyperactivity disorder risk seizures pediatric
… immunoglobulin levels among B-cell–depleting therapies and risk of infections in relapsing multiple sclerosis. Saidha S, …
… signs and symptoms of respiratory syncytial virus in high-risk adults and immunocompromised populations. Costello J, …
… to accept adverse event and cost trade-offs for reduced risk of non-melanoma skin cancer. Skelsey MK, Okun MM, Schiro …
Global Forum for Qualified Persons for Pharmacovigilance (QPPV) Share on: Tuesday, November 8 - Wednesday, November 9, 2022 Event website Alejandro Arana will be presenting an epidemiologist perspective on true adverse reactions in pharma research at the …
… disorders, obesity, sexual dysfunction, bipolar disorder, anxiety, depression, and chronic pain. Dr. Williams …
HRQOL Data Analysis Pooled Across Multiple Trials OPPORTUNITY Our client wanted to understand if their oncology product extended time to deterioration in patient-reported health-related quality of life (HRQOL) in 3 different tumor types using data …
… the 2022 American Society of Clinical Psychopharmacology. Risk of mortality associated with Pimavanserin compared with …
… of life and tolerability of loncastuximab tesirine in high-risk patients with relapsed/refractory diffuse large B-cell …
Bintu Sherif Biostatistics Vaccines Oncology Medical Technologies Infectious Disease Gastroenterology Diabetes & Endocrine Disorders Dermatology Cardiovascular Headquarters - Research Triangle Park, North Carolina, USA MS, Biostatistics BS, …
… milestones across the studies, while meeting deadlines for publications. OUR APPROACH We assembled a core team of …